¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"half fat cheese"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fascia-fat flap
    ±Ù¸·Áö¹æÇÇÆÇ
  • hypodermic fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • infrapatellar fat pad
    ¹«¸­¾Æ·¡Áö¹æÃ¼
  • milk fat
    ¿ìÀ¯Áö¹æ, À¯Áö¹æ
  • molecular fat
    ºÐÀÚÁö¹æ
  • mutton-fat keratic precipitate
    ±»±â¸§°¢¸·Ä§Âø¹°
  • masked fat
    ¼ûÀºÁö¹æ
  • neutral fat
    Áß¼ºÁö¹æ
  • nodular fat necrosis
    °áÀýÁö¹æ±«»ç
  • orbital fat
    ´«È®Áö¹æ, ¾È¿ÍÁö¹æ
  • pararenal fat
    ÄáÆÏÁÖÀ§Áö¹æ
  • pararenal fat pad
    ÄáÆÏÁÖÀ§Áö¹æµ¢ÀÌ, ÄáÆÏÁÖÀ§Áö¹æÃ¼
  • perirenal fat
    ÄáÆÏÁÖÀ§Áö¹æ
  • subcutaneous fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • subcutaneous fat necrosis
    ÇǺιØÁö¹æ±«»ç, ÇÇÇÏÁö¹æ±«»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • frequency selective fat suppression technique
    Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
  • hypodermic fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • masked fat
    °áÇÕÁö¹æ
  • milk fat
    ¿ìÀ¯Áö¹æ, À¯Áö¹æ
  • molecular fat
    ºÐÀÚÁö¹æ
  • neutral fat
    Áß¼ºÁö¹æ
  • pararenal fat
    ÄáÆÏÁÖÀ§Áö¹æÃ¼
  • perirenal fat
    ÄáÆÏÁö¹æÇǸ·
  • subcutaneous fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • infrapatellar fat pad
    ¹«¸­¹ØÁö¹æÃ¼
  • mutton-fat keratic precipitate
    ±»±â¸§°¢¸·Ä§Âø¹°
  • nodular fat necrosis
    °áÀýÁö¹æ±«»ç
  • subcutaneous fat necrosis
    ÇǺιØÁö¹æ±«»ç, ÇÇÇÏÁö¹æ±«»ç
  • traumatic fat necrosis
    ¿Ü»óÁö¹æ±«»ç
  • pararenal fat pad
    ÄáÆÏÁÖÀ§Áö¹æÃ¼
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • physical half life
    ¹°¸®Àû ¹Ý°¨±â(ÚªìµîÜ ÚâÊõÑ¢).
  • physical half-life
    ¹°¸®Àû¹Ý°¨±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • half-value layer
    ¹Ý°¡Ãþ
  • one and one-half syndrome
    1 1/2 ÁõÈıº
  • period of half decay
    ¹Ý¼è±â(ÚâáñÑ¢).
  • physical half life
    ¹°¸®Àû ¹Ý°¨±â(ÚªìµîÜ ÚâÊõÑ¢).
  • physical half-life
    ¹°¸®Àû¹Ý°¨±â
  • semitone [=half tone]
    ¹ÝÀ½
  • bone fat
    °ñÁö(Íéò·).
  • breast,traumatric fat necrosis
    ¿Ü»ó¼º Áö¹æ±«»ç (èâß¿àõò·Û¸ÎÕÞÝ)
  • brown fat
    ºê¶ó¿î Áö¹æ(ò·Û°)
  • brown fat
    °¥»öÁö¹æ(ü)(¡­ò·Û¸ô÷).
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷(¡­ò·Û¸ðÚòÄ).
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷
  • depot fat
    ÀúÀåÁö¹æ(îÍíúò·Û¸).
  • elbow fat pad sign
    ÆÈ²ÞÄ¡ Áö¹æ ÆÐµå¡ÈÄ(~ó£ý¦).
  • embolism,fat
    Áö¹æ(ò·Û¸)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FFS fat-free solids; fee for services
FFW fat-free weight
FFWW fat-free wet weight
FIH familial isolated hypoparathyroidism; fat-induced hyperglycemia
FMH family medical history; fat-mobilizing hormone; feto-maternal hemorrhage; fibromuscular hyperplasia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
T 1/2 The elimination half life
T 1/2 The half lives
t 1/2 The half time
T 1/2 The mean half-life
VHF Visual Half-Field
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • serum neutral fat
    Ç÷û Áß¼º Áö¹æ
    Ç÷û Áß¼º Áö¹æÀº ´ëºÎºÐÀÌ Æ®¸®±Û¸®¼¼¶óÀ̵åÀ̰í, ±× ³óµµ´Â À½½Ä¹°ÀÇ ¿µÇâÀ» ¹Þ´Â´Ù.
  • traumatic fat necrosis
    ¿Ü»ó¼º Áö¹æ ±«»ç
  • traumatric fat necrosis
    ¿Ü»ó¼º Áö¹æ ±«»ç
  • white fat tissue
    ¹é»ö Áö¹æÁ¶Á÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
half-time The time, in a first-order chemical (or enzymic) reaction, for half of the substance (substrate) to be converted or to disappear.
Compare: half-life.
(05 Mar 2000)
half-value layer <radiobiology> The thickness of a specified material (usually a specific absorber), which attenuates a beam of radiation so that the exposure rate or absorbed dose rate at a specified point is reduced by half.
(20 Sep 2002)
drug half-life The amount of time it takes for one-half of an administered drug to be lost through biological processes (metabolism and elimination).
(27 Sep 1997)
effective half-life <radiobiology> Time required for a radioactive substance contained in a biological system (such as a person or an animal) to reduce its radioactivity by half, as a combination result of radioactive decay and biological elimination from the system.
(09 Oct 1997)
elimination half-life <pharmacology> The time it takes for the body to eliminate or breakdown half of a dose of a pharmacologic agent.
(09 Oct 1997)
abdominal wall fat pad biopsy <investigation, procedure, surgery> The removal of a small specimen of the abdominal wall fat pad for microscopic examination. Often used in the diagnosis of amyloidosis. Performed with a local anaesthetic.
(25 Jun 1999)
Bichat's fat-pad An encapsuled mass of fat in the cheek on the outer side of the buccinator muscle, especially marked in the infant; supposed to strengthen and support the cheek during the act of sucking.
Synonym: corpus adiposum buccae, Bichat's fat-pad, Bichat's protuberance, fat body of cheek, sucking cushion, sucking pad, suctorial pad.
(05 Mar 2000)
brown fat A thermogenic type of adipose tissue containing a dark pigment, and arising during embryonic life in certain specific areas in many mammals, including man. It is prominent in the newborn of all species in which it occurs and remains a distinct and conspicuous tissue in the adults of certain species, especially those that hibernate. It is also called brown adipose tissue.
(12 Dec 1998)
brown fat cell <pathology> Brown fat is specialised for heat production and the adipocytes have many mitochondria in which an inner membrane protein can act as an uncoupler of oxidative phosphorylation allowing rapid thermogenesis.
(18 Nov 1997)
buccal fat-pad An encapsuled mass of fat in the cheek on the outer side of the buccinator muscle, especially marked in the infant; supposed to strengthen and support the cheek during the act of sucking.
Synonym: corpus adiposum buccae, Bichat's fat-pad, Bichat's protuberance, fat body of cheek, sucking cushion, sucking pad, suctorial pad.
(05 Mar 2000)
chicken fat clot Clot formed in vitro or postmortem from leukocytes and plasma of sedimented blood.
(05 Mar 2000)
combined fat-and carbohydrate-induced hyperlipaemia Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.
Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.
(05 Mar 2000)
white fat <anatomy> Connective tissue that has been specialised to store fat.
See: adipocyte.
(25 Jun 1999)
multilocular fat A thermogenic type of adipose tissue containing a dark pigment, and arising during embryonic life in certain specific areas in many mammals, including man. It is prominent in the newborn of all species in which it occurs and remains a distinct and conspicuous tissue in the adults of certain species, especially those that hibernate. It is also called brown adipose tissue.
(12 Dec 1998)
wool fat <physiology> A peculiar fatlike body, made up of cholesterin and certain fatty acids, found in feathers, hair, wool, and keratin tissues generally.
Under the same name, it is prepared from wool for commercial purposes, and forms an admirable basis for ointments, being readily absorbed by the skin.
Origin: L. Lana wool + oleum oil.
Source: Websters Dictionary
(01 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • macroni cheese
    ¸¶Ä«·Î´Ï¿¡ Ä¡Áî°¡·ç¸¦ Ãļ­ ±¸¿î ¿ä¸®
  • parmesan (cheese)
    (ÀÌÅ»¸®¾ÆÀÇ ¿ø»êÁö Parma¿¡¼­)ÆÄ¸£¸Þ»ê Ä¡Áî
  • pot cheese
    =COTTAGE CHEESE
  • pot cheese
    =cottage cheese
  • process cheese
    °¡°ø Ä¡Áî
  • process cheese
    ÇÁ·Î¼¼½º Ä¡Áî
  • processed cheese
    ÇÁ·Î¼¼½º Ä¡Áî
  • real cheese
    Áß¿ä Àι°;°Å¹°
  • sage cheese
    Ä¡ÁîÀÇ ÀÏÁ¾
  • about half way
    Áß°£Âë¿¡
  • half
    Àý¹Ý,Àý¹ÝÀÇ,Àý¹ÝÂë
  • half life
    ¹Ý°¨±â
  • half-seas-over
    ¾ó±ÙÈ÷ ÃëÇÑ
  • center half(back)
    (Ã౸.ÇÏŰ µîÀÇ)¼¾ÅÍ ÇÏÇÁ
  • first half
    »ó¹Ý±â;Àü¹Ý±â;Àü¹Ý;Àü±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á